dilaudid
Generic: hydromorphone hydrochloride
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
dilaudid
Generic Name
hydromorphone hydrochloride
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
hydromorphone hydrochloride 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
76045-010
Product ID
76045-010_97bfcafb-2037-47dc-a0ae-f7b8007c47df
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA019034
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2016-12-16
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76045010
Hyphenated Format
76045-010
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dilaudid (source: ndc)
Generic Name
hydromorphone hydrochloride (source: ndc)
Application Number
NDA019034 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 10 SYRINGE in 1 CARTON (76045-010-11) / 1 mL in 1 SYRINGE (76045-010-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "97bfcafb-2037-47dc-a0ae-f7b8007c47df", "openfda": {"unii": ["L960UP2KRW"], "rxcui": ["897756", "897757", "1433251", "1872265", "1872269", "1872752", "2277368", "2277370"], "spl_set_id": ["9eebd88a-5632-460f-b7b6-26c8a180540d"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 SYRINGE in 1 CARTON (76045-010-11) / 1 mL in 1 SYRINGE (76045-010-01)", "package_ndc": "76045-010-11", "marketing_start_date": "20161216"}], "brand_name": "Dilaudid", "product_id": "76045-010_97bfcafb-2037-47dc-a0ae-f7b8007c47df", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "76045-010", "dea_schedule": "CII", "generic_name": "Hydromorphone hydrochloride", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dilaudid", "active_ingredients": [{"name": "HYDROMORPHONE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "NDA019034", "marketing_category": "NDA", "marketing_start_date": "20161216", "listing_expiration_date": "20261231"}